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Abstract
We have previously reported that Potato virus X-expressed coat protein of Cucumber mosaic virus (CMV) formed virus-like particles
(VLPs), which served as carriers for display of diﬀerent neutralizing epitopes of Newcastle disease virus (NDV). In this work, we further
modiﬁed the puriﬁcation protocol of recombinant VLPs carrying short neutralizing epitopes of the NDV proteins and demonstrated that
self-contained capsid protein subunits of CMV transiently expressed from heterologous virus packaged into individual virions morphologically resembling and/or indistinguishable from wild type CMV particles. Homogeneity of the ﬁnal preparation represents an advance
over our previous study, where VLPs were found to be of variable size. Chickens immunized with puriﬁed VLPs developed antigen-speciﬁc response.
Published by Elsevier Inc.
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Newcastle Disease virus (NDV1), a member of avian
paramyxoviruses, is an economically important pathogen
of poultry causing a fatal and highly contagious viral disease aﬀecting most species of birds. There is no known
treatment for the disease. Prevention and control measures
include sanitary prophylaxis and vaccination with live and/
or oil emulsion vaccines containing B1 and La Sota strains,
which themselves may cause disease, depending on coinfections and environmental conditions [1]. Several epitopes of NDV were reported to have neutralizing activity
[2,3].
We reported previously on the development of protein
expression tool based on the Potato virus X (PVX) recom*
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binant vector carrying modiﬁed coat protein (CP) of
Cucumber mosaic virus (CMV) with inserted foreign epitopes [4,5]. In this study we continued the improvement
of the PVX/CMV CP-based system by modifying the puriﬁcation protocol of recombinant VLPs displaying antigenic
determinants of the NDV proteins: a 17 amino acid (aa)
neutralizing epitope of NDV’s fusion (F) protein (aa 65–
81, [3]), an eight aa neutralizing epitope of the NDV hemagglutinin-neuraminidase (HN) protein (aa 346–353 [2]),
and the same epitopes fused together in a tandem F–HN
construct. Using transmission electron microscopy (TEM)
we demonstrated that subunits of CMV capsid protein
packaged into individual virions morphologically resembling and/or indistinguishable from wild type CMV particles. Homogeneity of the ﬁnal preparation represents an
advance over our previous study, where VLPs were found
to be of variable size [4]. Chickens immunized with PVXderived CMV VLPs carrying eight amino acid-long epitope
of NDV hemagglutinin-neuraminidase protein (HN) developed antigen-speciﬁc response.
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Materials and methods
Plasmid construction
Engineering of PVX/CMV vector containing neutralizing epitopes of fusion (F) and HN proteins of NDV strain
La Sota was previously described in details [4]. Brieﬂy, the
recombinant CMV CP constructs with incorporated NDV
epitopes were ﬁrst cloned into PCR TOPO II vector (Invitrogen, Carlsbad, CA), following by digestion with EcoRV,
gel-puriﬁcation and subcloning into EcoRV-linerized and
dephosphorylated PVX-based vector pP2C2S (obtained
from D. Baulcombe, Sainsbury Laboratories, Norwich,
England). The correctness of all of the engineered constructs was conﬁrmed by nucleotide sequencing (ABIPRIZM 373A Genetic Analyzer, DNA Sequencing Facility, Center for Biosystems Research, College Park, MD)
and sequence data were analyzed using Lasergene software
by DNASTAR (Madison, WI).
Puriﬁcation of CMV
CMV VLPs were puriﬁed from 30 to 100 g of systemically infected leaf tissue by diﬀerential centrifugation using
the Lot method [6] with some modiﬁcations, as described in
Natilla et al. [4]. All puriﬁcations were performed within 2
weeks post inoculation to maintain recombinant form of
the virus. For further puriﬁcation of VLPs, linear sucrose
gradients were prepared by dissolving 25% (w/v) sucrose
in 0.05 M Na citrate, pH 6.5; ultracentrifuge tubes were
ﬁlled with sucrose and stored at 80 °C overnight or
longer. The gradient was formed by thawing the solution
at +4 °C before addition of 1.5 ml of the supernatant
obtained at the previous step. Gradients were fractionated
by centrifugation at 86,000g for 2.5 h (SW41 rotor) The
opalescent bands containing VLPs at or just below the middle of the gradient were collected, diluted with 0.05 M Na
citrate buﬀer, pH 6.5 and centrifuged for three more hours
at 80,000g (SW41 rotor). The ﬁnal pellets were resuspended
in sterile water or in Na citrate 0.05 M pH 6.5 and tested
for antigens by Western blot assays with antibodies speciﬁc
to CMV, HN, and F epitopes [4], and by TEM.

Chickens according to the company protocols (Paciﬁc
Immunology Corp., http://www.paciﬁcimmunology.com).
Aﬃnity puriﬁed CMV–HN antibodies company-tested by
ELISA for antigen speciﬁcity, were further used in our
lab in Western blot assays to test their reactivity against
NDV antigens. Western blotting was performed as previously described [4]. Escherichia coli-expressed NDV HN
protein and BPL (beta-propiolactone)-inactivated NDV
strain La Sota served as positive controls to assess the speciﬁcity of antibodies elicited against the CMV–HN antigen.
Puriﬁed preparation of plant virus unrelated to CMV,
Tobacco vein mottling potyvirus (TVMV), was used as a
negative control. The samples were subjected to denaturing, followed by Western blotting with CMV–HN or
CMV-speciﬁc antibody.
Results
Symptoms and stability of the recombinant virus in plants
As reported previously, PVX/CMV CP-WT virus
remained stable for at least 7 months after inoculation
[4]. Stability of the recombinant viral constructs carrying
CMV CP with diﬀerent antigenic determinants varied from
2 weeks to 1 month with longer epitopes being the least stable and the short HN epitope the most. The recombinants
remained stable for the same period of time after the second passage, when the second passage was performed 2–
3 dpi from primary transcript-inoculated plants. In all
cases, inoculation of Nicotiana benthamiana plants with
T7 RNA transcripts led to systemic infection visibly indistinguishable from wild type PVX symptoms 5–7 days postinoculation (not shown). Expression of CMV CP and
immunoreactivity of fused NDV epitopes was conﬁrmed
by Western blotting with corresponding antibodies to
CMV, HN, and F epitopes as shown previously in Natilla
et al. [4].
Puriﬁcation of VLPs

CMV VLPs were visualized by TEM. Carbon-coated
grids were incubated for 1 min with sucrose gradient-puriﬁed preparations of VLPs to capture virions, rinsed by
washing with 0.5 ml sterile H2O over the grid and stained
with a 2% aqueous solution of uranyl acetate. The grids
were examined under a JEOL 100-CXII electron microscope at magniﬁcations of 80,000–200,000.

A linear sucrose gradient separation step was added to
the recombinant PVX/CMV CP puriﬁcation procedure to
improve the quality of the ﬁnal preparation and to allow
an accurate view of VLP assembly and structure. The modiﬁed puriﬁcation method combined with sucrose-gradient
fractionation step and concentrating the VLPs by ultracentrifugation led to high concentrations of VLP in the samples. The yield, as determined by Bradford assay [7]
varied from 0.3 mg/ml up to 1.8 mg/ml, depending on the
amount of fresh tissue used for puriﬁcation (normally
20–200 g of infected leaves).

Immunization of chickens with plant-derived VLPs and
Western blotting assays

Visualization of CMV VLPs by transmission electron
microscopy

Puriﬁed samples of CMV–HN in concentration of
0.5 mg/ml were used to immunize Rhode Island Red

TEM examination of gradient-puriﬁed and concentrated
protein showed that PVX-derived WT CMV CP subunits

Electron microscopy
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or subunits carrying the NDV epitopes HN, F, and F/HN
assembled into characteristic virus-like particles undistinguishable from CMV virions (Fig. 1). Unlike the samples
of WT CP, which have infrequent and seldom seen PVX
virions, chimeric VLP preparations contained more copuriﬁed PVX particles.

Animal immune response to plant-derived VLPs
Animal immunization was performed to test the antigenic capacity of plant-derived VLP. Based on TEM examination, we have chosen puriﬁed preparations of PVX/
CMV-HN for the immunization experiments since they
contained visibly more VLPs. Antibodies, aﬃnity-puriﬁed
from immunized chickens bound speciﬁcally to the
CMV–HN antigen, the whole BPL-inactivated NDV strain
La Sota and to the E. coli-expressed HN protein in Western
blotting assays but not to the puriﬁed sample of unrelated
plant virus (Fig. 2A). Electrophoretic mobility of the puriﬁed NDV virions probed with antibodies speciﬁc to CMV–
HN revealed two protein bands with an apparent molecular weight of about 75 kDa and 63 kDa, presumably corresponding to the uncleaved HN0 precursor and cleaved
form of HN (Fig. 2A) [8–10]. On the contrary, probing
membranes with antibodies speciﬁc only to the CMV carrier, revealed a major band corresponding to the puriﬁed
VLPs of CMV–HN (Fig. 2B). Taken together, these experiments conﬁrm serological response developed in immu-
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nized chickens to the CMV carrier as well as to the
antigenic HN peptide displayed on its surface.
Discussion
A technology based on non-infectious but highly immunogenic virus-like particles is one of the most prominent
alternatives to the attenuated live vaccines that carry a signiﬁcant risk of virulent escape mutants [11]. Not only they
can mimic the structural appearance of the genuine pathogen and stimulate pathogen-speciﬁc immune response, but
they can also serve as adjuvants and vessels for delivery of
fused heterologous antigens. Making VLPs of animal and
human viruses in plants as well as using plant virus capsids
as carriers for delivery of immunogens has emerged as a
safe alternative to bacterial, yeast, insect or mammalian cell
production systems and represent a novel and inspiring
approach to elicit protective responses against a variety
of viral and bacterial infections [12,13].
The PVX/CMV CP transient expression system,
reported in our preceding study [4], is based on the production of CMV CP from PVX vector followed by assembly of
CMV-like particles. In our current work, a more thorough
investigation was made with emphasis on the ability of chimeric VLP with inserted foreign epitopes to form symmetrical CMV-shaped particles. Addition of a linear sucrosedensity gradient to the CMV puriﬁcation procedure significantly improved the uniformity of appearance of puriﬁed
CMV VLPs as compared to our previous data [4]. We

Fig. 1. Transmission electron microscopy of CMV VLPs, puriﬁed from Nicotiana bentahamiana plants by standard method [6], fractionated by sucrosedensity gradient and concentrated by high-speed centrifugation. (A) CMV CP–WT; (B) CMV CP–F; (C) CMV CP–HN; (D) CMV CP–F/HN. Bars,
100 nm.
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Fig. 2. Western blots, probed with antibodies to CMV–HN antigen (A) or CMV carrier (B). M, ColorBurst molecular weights (kDa) protein marker
(Sigma); 1, Puriﬁed CMV–HN antigen; 2, E. coli-expressed NDV HN protein; 3, BPL-inactivated NDV strain La Sota; 4, puriﬁed preparation of
unrelated virus potyvirus as a negative control. Arrows indicate position of the bands speciﬁc to the CMV–HN, bacterially expressed HN, and puriﬁed
NDV La Sota, respectively (A) or the position of CMV–HN antigen (B).

now were able to demonstrate unmistakably that chimeric
CMV CP capsids are packaged into typical CMV-like virions. These VLPs are with characteristic structural look and
shape of CMV and hence none of the native CMV RNA 3
regions except CP ORF itself is required for assembly of
CMV virions. As we demonstrated earlier [4], PVX-derived
CMV VLPs may incorporate not only RNA which encodes
CMV CP but also a set of PVX subgenomic RNAs downstream from the triple gene block (TGB) including PVX CP
RNA. It is evident therefore that if there are any requirements in additional structural elements for CMV to package into the full-sized particles, heterologous PVX
subgenomic RNAs may eﬃciently compensate for them.
Gradient-fractionation apparently ﬁltered only uniformsized particles of CMV CP–WT and chimeric CMV CPs.
A presence of PVX is not expected to have any inﬂuence
on the immunogenic properties of the CMV CP–HN antigen since co-puriﬁed PVX virions do not contain the antigenic epitopes.
Immunization of chickens with plant-derived CMV
VLPs carrying HN peptide elicited antibodies, which speciﬁcally recognized puriﬁed NDV virions and bacterially
expressed HN protein. Apparently, antibody raised against
plant-manufactured antigen detected both HN0 precursor
protein and cleaved form of HN and, therefore, are probably not conformationally-sensitive. This may indicate that
the HN epitope presented on CMV particles maintains its
linear structure as it was demonstrated for the corresponding antigenic determinant of the HN glycoprotein [14,15].
Whereas these observations could suggest a possible application of the plant-made protein for prophylactic immunization, the CMV–HN antigen did not protect immunized
chickens against experimental challenge with NDV (C.
Buanovoglia, A. Natilla, L.G. Nemchinov, unpublished

results). Although relevant only to this particular epitope
of the virus, this may imply ineﬀectiveness of a single-epitope approach for the design of plant anti-NDV vaccine.
However, diagnostic applications of the non-infectious,
plant-derived protein to detect NDV-speciﬁc antibodies
in serum samples and egg yolk look more feasible.
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